BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Oct 05, 2012
 |  BC Extra  |  Company News

Newco Katama in deal for Sanochemia's tolperisone

Sanochemia Pharmazeutika AG (Xetra:SAC) granted newco Katama Pharmaceuticals Inc. (San Diego, Calif.) exclusive rights in North America to develop and commercialize spasticity product tolperisone....

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >